• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[用结核菌素皮肤试验评估美洲原住民结核分枝杆菌感染率:文献综述]

[Tuberculin skin test to estimate the prevalence of Mycobacterium tuberculosis infection in indigenous populations in the Americas: a literature review].

作者信息

Basta Paulo Cesar, Camacho Luiz Antonio Bastos

机构信息

Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, Rua Leopoldo Bulhōes 1480, Rio de Janeiro, RJ 21041-210, Brazil.

出版信息

Cad Saude Publica. 2006 Feb;22(2):245-54. doi: 10.1590/s0102-311x2006000200002. Epub 2006 Feb 20.

DOI:10.1590/s0102-311x2006000200002
PMID:16501737
Abstract

A systematic review was conducted on articles reporting tuberculin surveys to estimate the prevalence and annual risk of tuberculosis infection (ARI) in indigenous peoples of the Americas. MEDLINE and LILACS databases were searched using the following combination of descriptors: "tuberculosis", "South American Indians", "North American Indians", "tuberculin skin test", "PPD", "risk assessment", and "BCG vaccine". Longitudinal and cross-sectional studies published from 1974 to 2004 were selected if the outcome was Mycobacterium tuberculosis infection defined by tuberculin reactions > 5mm or > 10mm. From a total of 54 candidate studies generated with the descriptors, 16 were selected for review. Altogether, they comprised 13,186 individuals, 50% of whom were below 15 years of age. Estimates of prevalence of tuberculosis infection ranged from 0% to 93.4%, whereas the ARI ranged from 0% to 35.4%. Analysis of heterogeneity in environmental conditions and methods of infection assessment in the studies showed that the tuberculin test is useful for clinical decisions (e.g., to initiate chemoprophylaxis), and that tuberculin surveys are useful to assess tuberculosis control measures among indigenous peoples.

摘要

对报告结核菌素调查的文章进行了系统综述,以估计美洲原住民中结核病感染的患病率和年度风险(ARI)。使用以下描述符组合在MEDLINE和LILACS数据库中进行搜索:“结核病”、“南美印第安人”、“北美印第安人”、“结核菌素皮肤试验”、“PPD”、“风险评估”和“卡介苗”。如果结果是由结核菌素反应>5mm或>10mm定义的结核分枝杆菌感染,则选择1974年至2004年发表的纵向和横断面研究。在使用这些描述符生成的总共54项候选研究中,选择了16项进行综述。它们总共包括13186人,其中50%年龄在15岁以下。结核病感染患病率估计范围为0%至93.4%,而ARI范围为0%至35.4%。对研究中环境条件和感染评估方法的异质性分析表明,结核菌素试验有助于临床决策(例如,启动化学预防),并且结核菌素调查有助于评估原住民中的结核病控制措施。

相似文献

1
[Tuberculin skin test to estimate the prevalence of Mycobacterium tuberculosis infection in indigenous populations in the Americas: a literature review].[用结核菌素皮肤试验评估美洲原住民结核分枝杆菌感染率:文献综述]
Cad Saude Publica. 2006 Feb;22(2):245-54. doi: 10.1590/s0102-311x2006000200002. Epub 2006 Feb 20.
2
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection.一项关于用于检测结核感染的快速诊断检测的系统评价。
Health Technol Assess. 2007 Jan;11(3):1-196. doi: 10.3310/hta11030.
3
Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment.结核病患者接触者潜伏性结核感染(LTBI)筛查策略的经济评价:系统评价和质量评估。
Int J Environ Res Public Health. 2022 Oct 19;19(20):13529. doi: 10.3390/ijerph192013529.
4
Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status.症状和胸部 X 线筛查在 HIV 阴性的成年人和 HIV 状态未知的成年人中的活动性肺结核。
Cochrane Database Syst Rev. 2022 Mar 23;3(3):CD010890. doi: 10.1002/14651858.CD010890.pub2.
5
Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.用于肺外结核病和利福平耐药性的Xpert MTB/RIF检测
Cochrane Database Syst Rev. 2018 Aug 27;8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
9
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
10
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.

引用本文的文献

1
Chronic symptoms and pulmonary dysfunction in post-tuberculosis Brazilian patients.巴西肺结核康复患者的慢性症状和肺功能障碍
Braz J Infect Dis. 2015 Sep-Oct;19(5):492-7. doi: 10.1016/j.bjid.2015.06.005. Epub 2015 Aug 5.
2
Impact of latent infection treatment in indigenous populations.土著人群潜伏感染治疗的影响。
PLoS One. 2013 Jul 31;8(7):e71201. doi: 10.1371/journal.pone.0071201. Print 2013.